http://healthcarefirms.com The Healthcare Industry Website Directory - Coming Soon Sat, 05 Feb 2011 02:14:44 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 http://healthcarefirms.com/cannabis-science-inc/ http://healthcarefirms.com/cannabis-science-inc/#comments Wed, 03 Mar 2010 00:29:30 +0000 admin Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. The Company is dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

]]> http://healthcarefirms.com/cannabis-science-inc/feed/ 0 http://healthcarefirms.com/pain-therapeutics-inc/ http://healthcarefirms.com/pain-therapeutics-inc/#comments Tue, 02 Mar 2010 18:40:16 +0000 admin Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. Its lead drug candidate, REMOXY, is a strong painkiller with a unique formulation designed to reduce potential risks of unintended use. It is also developing novel drugs in the area of hematology/oncology. It has in clinical development a monoclonal antibody to treat metastatic melanoma, a deadly form of skin cancer. It also has in pre-clinical development a drug candidate to treat hemophilia.

]]> http://healthcarefirms.com/pain-therapeutics-inc/feed/ 0 http://healthcarefirms.com/pozen-inc/ http://healthcarefirms.com/pozen-inc/#comments Tue, 02 Mar 2010 18:40:16 +0000 admin POZEN Inc., headquartered in Chapel Hill, NC, is a pharmaceutical company committed to transforming medicine that transforms lives. Since its founding in 1996, POZEN has successfully created novel pharmacologic agents primarily for pain and pain-related conditions by combining existing drug therapies that result in superior patient outcomes.

]]> http://healthcarefirms.com/pozen-inc/feed/ 0 http://healthcarefirms.com/map-pharmaceuticals-inc/ http://healthcarefirms.com/map-pharmaceuticals-inc/#comments Tue, 02 Mar 2010 18:40:16 +0000 admin MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

]]> http://healthcarefirms.com/map-pharmaceuticals-inc/feed/ 0 http://healthcarefirms.com/ym-biosciences-inc/ http://healthcarefirms.com/ym-biosciences-inc/#comments Tue, 02 Mar 2010 18:40:16 +0000 admin YM BioSciences Inc. is a life sciences product development. Together with the products from the merged Australian company, Cytopia Ltd (now YM Australia), the Company is currently developing four late-stage products: nimotuzumab, an EGFR-targeting Affinity-Optimized Antibody(TM); CYT 387, a JAK 1/2 small molecule inhibitor, CYT 997, a potent, vascular disrupting agent and AeroLEF(R), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization

]]> http://healthcarefirms.com/ym-biosciences-inc/feed/ 0 http://healthcarefirms.com/vertex-pharmaceuticals/ http://healthcarefirms.com/vertex-pharmaceuticals/#comments Tue, 02 Mar 2010 18:40:16 +0000 admin Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

]]> http://healthcarefirms.com/vertex-pharmaceuticals/feed/ 0 http://healthcarefirms.com/durect-corp/ http://healthcarefirms.com/durect-corp/#comments Fri, 26 Feb 2010 18:31:21 +0000 admin DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR™, and TRANSDUR™-Sufentanil. DURECT’s proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.

]]> http://healthcarefirms.com/durect-corp/feed/ 0